Improving CAR T cell immunotherapy-mediated remissions for pediatric leukemia

被引:6
作者
Barrett, David M. [1 ]
机构
[1] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Cell Therapy Program, Philadelphia, PA 19104 USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDREN;
D O I
10.1172/JCI128743
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chimeric antigen receptor (CAR) T cells are an effective therapy for relapsed or refractory pediatric B cell leukemia. Analysis of the starting material, the T cells collected from the patient prior to CAR manufacture, reveals possible biomarkers of cells destined to perform poorly in patients. Long-term follow-up shows that long periods of B cell aplasia, a marker of in vivo CAR activity, are associated with longer remission but also a higher chance of antigen-negative relapse. The role of transplantation as consolidative therapy is unclear in this nonrandomized data, but clearly warrants further study.
引用
收藏
页码:1842 / 1844
页数:3
相关论文
共 17 条
[1]   Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates [J].
Berger, Carolina ;
Jensen, Michael C. ;
Lansdorp, Peter M. ;
Gough, Mike ;
Elliott, Carole ;
Riddell, Stanley R. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :294-305
[2]   Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study [J].
Borowitz, Michael J. ;
Devidas, Meenakshi ;
Hunger, Stephen P. ;
Bowman, W. Paul ;
Carroll, Andrew J. ;
Carroll, William L. ;
Linda, Stephen ;
Martin, Paul L. ;
Pullen, D. Jeanette ;
Viswanatha, David ;
Willman, Cheryl L. ;
Winick, Naomi ;
Camitta, Bruce M. .
BLOOD, 2008, 111 (12) :5477-5485
[3]   Naive T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers [J].
Das, Rajat K. ;
Vernau, Lauren ;
Grupp, Stephan A. ;
Barrett, David M. .
CANCER DISCOVERY, 2019, 9 (04) :492-499
[4]   CD19 CAR T cell product and disease attributes predict leukemia remission durability [J].
Finney, Olivia C. ;
Brakke, Hannah ;
Rawlings-Rhea, Stephanie ;
Hicks, Roxana ;
Doolittle, Danielle ;
Lopez, Marisa ;
Futrell, Ben ;
Orentas, Rimas J. ;
Li, Daniel ;
Gardner, Rebecca ;
Jensen, Michael C. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (05) :2123-2132
[5]   Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia [J].
Fraietta, Joseph A. ;
Lacey, Simon F. ;
Orlando, Elena J. ;
Pruteanu-Malinici, Iulian ;
Gohil, Mercy ;
Lundh, Stefan ;
Boesteanu, Alina C. ;
Wang, Yan ;
O'Connor, Roddy S. ;
Hwang, Wei-Ting ;
Pequignot, Edward ;
Ambrose, David E. ;
Zhang, Changfeng ;
Wilcox, Nicholas ;
Bedoya, Felipe ;
Dorfmeier, Corin ;
Chen, Fang ;
Tian, Lifeng ;
Parakandi, Harit ;
Gupta, Minnal ;
Young, Regina M. ;
Johnson, F. Brad ;
Kulikovskaya, Irina ;
Liu, Li ;
Xu, Jun ;
Kassim, Sadik H. ;
Davis, Megan M. ;
Levine, Bruce L. ;
Frey, Noelle V. ;
Siegel, Donald L. ;
Huang, Alexander C. ;
Wherry, E. John ;
Bitter, Hans ;
Brogdon, Jennifer L. ;
Porter, David L. ;
June, Carl H. ;
Melenhorst, J. Joseph .
NATURE MEDICINE, 2018, 24 (05) :563-+
[6]   Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia [J].
Fraietta, Joseph A. ;
Beckwith, Kyle A. ;
Patel, Prachi R. ;
Ruella, Marco ;
Zheng, Zhaohui ;
Barrett, David M. ;
Lacey, Simon F. ;
Melenhorst, Jan Joseph ;
McGettigan, Shannon E. ;
Cook, Danielle R. ;
Zhang, Changfeng ;
Xu, Jun ;
Do, Priscilla ;
Hulitt, Jessica ;
Kudchodkar, Sagar B. ;
Cogdill, Alexandria P. ;
Gill, Saar ;
Porter, David L. ;
Woyach, Jennifer A. ;
Long, Meixiao ;
Johnson, Amy J. ;
Maddocks, Kami ;
Muthusamy, Natarajan ;
Levine, Bruce L. ;
June, Carl H. ;
Byrd, John C. ;
Maus, Marcela V. .
BLOOD, 2016, 127 (09) :1117-1127
[7]   CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy [J].
Fry, Terry J. ;
Shah, Nirali N. ;
Orentas, Rimas J. ;
Stetler-Stevenson, Maryalice ;
Yuan, Constance M. ;
Ramakrishna, Sneha ;
Wolters, Pamela ;
Martin, Staci ;
Delbrook, Cindy ;
Yates, Bonnie ;
Shalabi, Haneen ;
Fountaine, Thomas J. ;
Shern, Jack F. ;
Majzner, Robbie G. ;
Stroncek, David F. ;
Sabatino, Marianna ;
Feng, Yang ;
Dimitrov, Dimiter S. ;
Zhang, Ling ;
Sang Nguyen ;
Qin, Haiying ;
Dropulic, Boro ;
Lee, Daniel W. ;
Mackall, Crystal L. .
NATURE MEDICINE, 2018, 24 (01) :20-+
[8]   Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults [J].
Gardner, Rebecca A. ;
Finney, Olivia ;
Annesley, Colleen ;
Brakke, Hannah ;
Summers, Corinne ;
Leger, Kasey ;
Bleakley, Marie ;
Brown, Christopher ;
Mgebroff, Stephanie ;
Kelly-Spratt, Karen S. ;
Hoglund, Virginia ;
Lindgren, Catherine ;
Oron, Assaf P. ;
Li, Daniel ;
Riddell, Stanley R. ;
Park, Julie R. ;
Jensen, Michael C. .
BLOOD, 2017, 129 (25) :3322-3331
[9]   Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy [J].
Hay, Kevin A. ;
Gauthier, Jordan ;
Hirayama, Alexandre V. ;
Voutsinas, Jenna M. ;
Wu, Qian ;
Li, Daniel ;
Gooley, Ted A. ;
Cherian, Sindhu ;
Chen, Xueyan ;
Pender, Barbara S. ;
Hawkins, Reed M. ;
Vakil, Aesha ;
Steinmetz, Rachel N. ;
Schoch, Gary ;
Chapuis, Aude G. ;
Till, Brian G. ;
Kiem, Hans-Peter ;
Ramos, Jorge D. ;
Shadman, Mazyar ;
Cassaday, Ryan D. ;
Acharya, Utkarsh H. ;
Riddell, Stanley R. ;
Maloney, David G. ;
Turtle, Cameron J. .
BLOOD, 2019, 133 (15) :1652-1663
[10]   CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity [J].
Jacoby, Elad ;
Nguyen, Sang M. ;
Fountaine, Thomas J. ;
Welp, Kathryn ;
Gryder, Berkley ;
Qin, Haiying ;
Yang, Yinmeng ;
Chien, Christopher D. ;
Seif, Alix E. ;
Lei, Haiyan ;
Song, Young K. ;
Khan, Javed ;
Lee, Daniel W. ;
Mackall, Crystal L. ;
Gardner, Rebecca A. ;
Jensen, Michael C. ;
Shern, Jack F. ;
Fry, Terry J. .
NATURE COMMUNICATIONS, 2016, 7